Big pharma investment “very important”, says peer.
But J&J set to snub the UK despite government Life Sciences strategy
Drugmaker concerned over access to new drugs
Make NHS best place to research and launch drugs, says ABPI.
No guarantee of funding for new medicines funding – which is being squeezed again